Report
EUR 174.51 For Business Accounts Only

Moody's Ratings takes action on 18 ratings from 11 US RMBS transactions

Moody's Ratings (Moody's) has upgraded the ratings of 17 bonds and downgraded the rating of one bond from 11 US residential mortgage-backed transactions (RMBS), backed by subprime and Alt-A mortgages issued by multiple issuers. Please click on this link /viewresearchdoc.aspx?...
Underlyings
Argent Securities Trust 2006-W1

Centex Home Equity Loan Trust 2002-A

CWABS, Inc. Asset-Backed Certificates, Series 2004-1

Fannie Mae Grantor Trust 2004-T5

Fremont Home Loan Trust 2005-D

Impac CMB Trust Series 2005-1 Collateralized Asset-Backed Bonds, Series 2005-1

Park Place Securities, Inc., Asset-Backed Pass-Through Certificates, Series 2005-WCH1

RAMP Series 2004-RS8 Trust

RASC Series 2003-KS7 Trust

RASC Series 2005-AHL3 Trust

Structured Asset Securities Corp Trust 2005-NC2

Provider
Moody's Investors Service
Moody's Investors Service

Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:

  • 130 countries
    11,000 corporate issuers
    21,000 public finance issuers
    76,000 structured finance obligations



Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.



Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions. 

Other Reports on these Companies
Other Reports from Moody's Investors Service

ResearchPool Subscriptions

Get the most out of your insights

Get in touch